Weight-loss surgery to treat atrial fibrillation
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether weight-loss surgery can help control or eliminate atrial fibrillation (an irregular heartbeat) in people with obesity. If you qualify, you would receive either gastric bypass or sleeve gastrectomy and be monitored for changes in your heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your body mass index (BMI) is between 35 and 65.
- You have atrial fibrillation that causes symptoms, confirmed by a heart monitor or EKG.
- You are healthy enough for general anesthesia and surgery.
- You have not had weight-loss surgery before (unless a gastric balloon or band was removed more than a year ago).
- You agree to use birth control for 2 years if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the heart rhythm condition atrial fibrillation. If you have AFib and are overweight or obese, this trial may be an option for you.
This trial tests if weight loss surgery can help people with heart failure and atrial fibrillation (an irregular heartbeat) improve their heart condition. You may join if you are between 45 and 70, have a BMI of 32 to 40, and have mild to moderate heart failure with preserved pumping function.
This trial tests whether a weight-loss medication called tirzepatide (given as a shot) helps prevent atrial fibrillation from coming back after a catheter ablation procedure. It is for people who have both obesity and atrial fibrillation, and it may help improve heart health by reducing weight and inflammation.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
This study tests whether tirzepatide (a weekly injection for weight loss and diabetes) can prevent atrial fibrillation from coming back after catheter ablation, in people with obesity and heart failure with preserved ejection fraction. It may help by reducing weight and improving heart function.
This study looks at whether losing weight can help reduce the progression of atrial fibrillation (an irregular heartbeat). It might help people who are overweight and have AF symptoms.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.